Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ARIS MINING ANNOUNCES STEADY RAMP-UP AT SEGOVIA FOLLOWING SECOND MILL COMMISSIONING IN LATE JUNE
-
Health In Tech Strengthens Leadership Team to Accelerate AI Innovation and Drive Enterprise Revenue Growth
-
CME Group Inc. Announces Third-Quarter 2025 Earnings Release, Conference Call
-
Tradeweb Reports August 2025 Total Trading Volume of $54.1 Trillion and Average Daily Volume of $2.5 Trillion
-
NextGen Digital Platforms Inc. Appoints Mark Creaser to Advisory Board
-
Realbotix Announces Change of Auditor
-
Purpose Investments Launches USD ETF Series for Its Purpose Global Bond Fund
-
iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
-
Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
-
Saia Provides Third Quarter LTL Operating Data
-
Supreme Critical Metals Inc., Announces Ron Shenton to the Advisory Board
-
NetDragon Showcases AI-Powered Education Solutions at UNESCO Digital Learning Week 2025
-
K Wave Media Subsidiary Solaire Partners Selected to Manage $28 Million IPTV Fund, Signaling New Era for K-Content Market
-
Final terms for bonds to be listed 10th September 2025
-
Stora Enso's Shareholders' Nomination Board composition
-
Beko Presents AI-Driven Smart Appliances, Advancing Sustainability and Consumer Convenience
-
Bluevale Capital Completes London, Ontario's First Office-to-Residential Conversion at 376 Richmond Street: Modern Urban Living in Downtown London
-
Ironseed Music Debuts with "The Price Was Paid"
-
Hainan-Hong Kong Cultural Tourism Integration Upgrades "One-Trip, Multiple-Stops" Travel Experience in China
-
REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE® Trial of RGX-121 for Treatment of MPS II
-
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
-
Bunker Hill Announces C$45 Million “Bought Deal” Private Placement of Units
-
Form 8.3 - Unite Group Plc
-
IFA: Arspura Presents IQV ™ Smart Extractor Hood P1
-
High 5 Plumbing, Heating, Cooling & Electric warns homeowners of mold risks
-
Smart home technology helps homeowners save money and boost efficiency
-
Form 8.3 - Life Science REIT Plc
-
Crypto Mining Stocks - from Dogecoin to Bitcoin, the Revolution Continues
-
SANTA FE MANSION TO SELL IN RARE, NO RESERVE AUCTION
-
Form 8.3 - Empiric Student Property Plc
-
Marex Group plc to Participate in Upcoming Barclays Global Financial Services Conference
-
IM Cannabis Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement
-
Announcement - Entitlement Offer Fully Subscribed
-
New Found Gold and Maritime Enter into Definitive Agreement to Combine; Combination Creates an Emerging Canadian Gold Producer
-
Aldebaran Announces Intention to Spin Out Northern Argentina Exploration Projects into a New Argentine-Focused Exploration Company and Provides an Update on the Altar PEA
-
Keeper Security Announces Integration With CrowdStrike Falcon Next-Gen SIEM
-
Koryx Copper Announces Planned Continuation to Luxembourg
-
1° of Separation Launches Global Comedy Tour for Suicide Prevention Month
-
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Foresight Diagnostics to Present Clinical Performance Data on Foresight CLARITY™ MRD at IASLC 2025 World Conference on Lung Cancer
-
Supremex Announces Appointment of Chief Financial Officer
-
RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights
-
LS Investment Team: Driving Professional Investment and Social Responsibility for a Sustainable Future
-
On National Cellulite Day, 80% of Women Say Creams and Gadgets Don't Work¹
-
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Deerfield Management Announces Sale of Melinta Therapeutics
-
Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)
-
Mobix Labs Sweetens Offer to Acquire Peraso with Cash and Stock Deal Delivering Value Now and Growth Ahead
-
RSA Announces CEO Transition to Lead New Phase of Growth
